On October 19, 2023, GoodRx announced that it’s partnering with the insulin manufacturer Sanofi to supply a brand new avenue for individuals with diabetes in america to access the long-acting insulin Lantus for under $35 per vial.
Insulin remains to be unaffordable for many individuals
Nearly 40 million Americans live with diabetes, and over 8 million of them need insulin to survive. The variety of Americans who’ve diabetes is increasing yearly, and plenty of are still struggling to afford their insulin, often selecting between their life-saving medications and rent or food to get by.
Many solutions have been brought forth: 25 states and the District of Columbia have passed insulin copay cap laws, targeting state-regulated health plans and limiting the quantity of out-of-pocket costs for insulin. Congress has held hearings on the difficulty and the three predominant insulin manufacturers within the U.S. have also voluntarily reduced their list prices in recent months.
Nonetheless, many persons are still falling through the cracks on reasonably priced insulin.
Namely, people who find themselves uninsured. Nearly 30 million Americans, lots of whom have diabetes, are still uninsured and are in desperate need for reasonably priced insulin and other medications.
A giant insulin-access win
Earlier this 12 months Sanofi lowered the value of Lantus insulin to $35 for all patients with industrial insurance (which works into effect January 1, 2024). Seeking to meet the needs of more individuals with diabetes, Sanofi partnered with GoodRx to leverage their reach to broaden access much more.
Through its Pharma Manufacturer Solutions program, GoodRx has worked with 19 of the highest 20 pharmaceutical manufacturers to deliver savings on to patients. GoodRx utilizes tools corresponding to copay cards, patient savings programs and programs where manufacturers can offer money prices for his or her medications.
GoodRx is a vital partner to manufacturers like Sanofi to assist increase their reach to people who find themselves in search of reasonably priced ways to access the insulin they need.
Effective today, all Americans with a sound prescription for Lantus, no matter insurance status, can utilize GoodRx at over 70,000 retail pharmacies across the country and access a 30-day supply of Lantus for under $35.
“Efforts to make insulin more accessible have been on the forefront of the news for months, and a critical piece of delivering on this promise is making it so simple as possible for patients to get the lower cost right at their regular pharmacy counter. Sanofi is taking motion and providing Americans who need insulin with the flexibility to access Lantus in a simple and reasonably priced way, no matter insurance status. We’re proud to collaborate with them on this initiative,” said Dorothy Gemmell, chief industrial officer at GoodRx.
Find out how to access the coupon
People should visit the GoodRx website to access the $35 coupon. The coupon might be redeemed at any pharmacy that accepts GoodRx, including Walmart, Walgreens and CVS.
“Sanofi believes that nobody should struggle to pay for his or her insulin,” said Olivier Bogillot, head of U.S. general medicines at Sanofi. “We’re proud to collaborate with GoodRx to construct on our existing suite of industry-leading savings programs to expand access and affordability pathways that may bring convenient and meaningful impact on the pharmacy counter.”
Individuals who take insulin require consistently reasonably priced and predictable sources of insulin in any respect times. In the event you or a loved one struggle to afford or access insulin, visit getinsulin.org.